Managing complications of hypertension in aortic valve stenosis patients

References

• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation. 2014;129:399-410.
   Google Scholar
• Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2013;99:396–400.
   PubMed Web of Science ®Google Scholar
• Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.
   PubMed Web of Science ®Google Scholar
• Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, Echocardiographic, Exercise Predictors Outcome Circulation. 1997;95:2262–2270.
   Google Scholar
• Stewart RA, Kerr AJ, Whalley GA, et al. New Zealand Heart Valve Study Investigators. Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis. Eur Heart J. 2010;31:2216–2222.
   PubMedGoogle Scholar
• Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J. 2004;25:199–205.
   PubMed Web of Science ®Google Scholar
• Ngo MV, Gottdiener JS, Fletcher RD, et al. Smoking and obesity are associated with the progression of aortic stenosis. Am J Geriatr Cardiol. 2001;10:86–90.
   PubMedGoogle Scholar
• Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634.
   PubMed Web of Science ®Google Scholar
• Kamalesh M, Ng C, El Masry H, et al. Does diabetes accelerate progression of calcific aortic stenosis? Eur J Echocardiogr. 2009;10:723–725.
   PubMed Web of Science ®Google Scholar
• Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397.
   PubMed Web of Science ®Google Scholar
• Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–1356.
   PubMed Web of Science ®Google Scholar
• Chan KL, Teo K, Dumesnil JG, et al. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis. Results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121:306–314.
   PubMed Web of Science ®Google Scholar
• Rieck ÅE, Cramariuc D, Boman K, et al. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension. 2012;60:90–97.
   PubMed Web of Science ®Google Scholar
• Rogge BP, Cramariuc D, Lønnebakken MT, et al. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis). J Am Coll Cardiol. 2013;62:1683–1690.
   PubMed Web of Science ®Google Scholar
• Capoulade R, Clavel MA, Dumesnil JG, et al. ASTRONOMER investigators. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol. 2012;60:216–223.
   PubMed Web of Science ®Google Scholar
• Pagé A, Dumesnil JG, Clavel MA, et al. ASTRONOMER investigators. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol. 1867–74;2010:55.
   Google Scholar
• Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466–472.
   PubMed Web of Science ®Google Scholar
• Lindroos M, Kupari M, Heikkilä J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–1225.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al.ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;Aug25 DOI: 10.1093/eurheartj/ehy339
   Web of Science ®Google Scholar
• Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. European Heart Journal. 2003;24:1231–1243.
   PubMed Web of Science ®Google Scholar
• Saeed S, Rajani R, Seifert R, et al. Exercise testing in asymptomatic patients with moderate or severe aortic stenosis. Heart. 2018 Apr 13:312939. DOI:10.1136/heartjnl-2018-312939
   Google Scholar
• Lindman BR, Otto CM, Douglas PS, et al. Blood pressure and arterial load after transcatheter aortic valve replacement for aortic stenosis. Circ Cardiovasc Imaging. 2017;10:e006308.
   PubMed Web of Science ®Google Scholar
• Oliver JM, Alonso-Gonzalez R, Gonzalez AE, et al. Risk of aortic root or ascending aorta complications in patients with bicuspid aortic valve with and without coarctation of the aorta. Am J Cardiol. 2009;104:1001–1006.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008 Nov;9(6):809–815.
   PubMed Web of Science ®Google Scholar
• Rieck AE, Cramariuc D, Staal EM, et al. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). J Hypertens. 2010;28:377–383.
   PubMed Web of Science ®Google Scholar
• Lund BP, Gohlke-Bärwolf C, Cramariuc D, et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am J Cardiol. 2010;105:1456–1460.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Gerdts E, Hjertaas JJ, et al. Myocardial function in aortic stenosis-insights from radial multilayer Doppler strain. Cardiovasc Ultrasound. 2015;13:8.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Joshi S, Murigu T, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:50.
   PubMed Web of Science ®Google Scholar
• Tuseth N, Cramariuc D, Rieck AE, et al. Gerdts E: asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). Blood Press. 2010;19:140–144.
   PubMed Web of Science ®Google Scholar
• Hess OM, Schneider J, Turina M, et al. Krayenbuehl HP: asymmetric septal hypertrophy in patients with aortic stenosis: an adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? J Am Coll Cardiol. 1983;1:783–789.
   PubMed Web of Science ®Google Scholar
• Lindmann BR, Otto CM. Time to treat hypertension in patients with aortic stenosis. Circulation. 2013;128:1281–1283.
   PubMedGoogle Scholar
• Cioffi G, Faggiano P, Vizzardi E, et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart. 2011;97:301–307.
   PubMed Web of Science ®Google Scholar
• Kusunose K, Goodman A, Parikh R, et al. Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ Cardiovasc Imaging. 2014;7:938–945.
   PubMed Web of Science ®Google Scholar
• Treibel TA, Kozor R, Schofield R, et al. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol. 2018;71:860–871.
   PubMed Web of Science ®Google Scholar
• Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J. 2009;30:3037–3047.
   PubMed Web of Science ®Google Scholar
• Pai RG, Varadarajan P, Razzouk A. Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Ann Thorac Surg. 2008;86:1781–1789.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Rogge BP, Lønnebakken MT, et al. Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart. 2015;101:209–214.
   PubMed Web of Science ®Google Scholar
• Attias D, Macron L, Dreyfus J, et al. Relationship between longitudinal strain and symptomatic status in aortic stenosis. J Am Soc Echocardiogr. 2013;26:868–874.
   PubMed Web of Science ®Google Scholar
• Carstensen HG, Larsen LH, Hassager C, et al. Basal longitudinal strain predicts future aortic valve replacement in asymptomatic patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2016;17:283–292.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–289.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
   PubMed Web of Science ®Google Scholar
• Bahlmann E, Cramariuc D, Minners J, et al. Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. Eur Heart J Cardiovasc Imaging. 2017;18:404–412.
   PubMed Web of Science ®Google Scholar
• Bahlmann E, Cramariuc D, Gerdts E, et al. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy. JACC Cardiovasc Imaging. 2010;3:555–562.
   PubMed Web of Science ®Google Scholar
• Bahlmann E, Gerdts E, Cramariuc D, et al. Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation. 2013;127:1149–1156.
   PubMed Web of Science ®Google Scholar
• Saeed S, Senior R, Chahal NS, et al. Lower trans-aortic flow rate is associated with increased mortality in aortic valve stenosis. JACC Cardiovasc Imaging. 2017;10:912–920.
   PubMed Web of Science ®Google Scholar
• Lønnebakken MT, De Simone G, Saeed S, et al. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. Heart. 2017;103:1443–1448.
   PubMed Web of Science ®Google Scholar
• Capoulade R, Le Ven F, Clavel MA, et al. Echocardiographic predictors of outcomes in adults with aortic stenosis. Heart. 2016;102:934–942.
   PubMed Web of Science ®Google Scholar
• Rogge BP, Gerdts E, Cramariuc D, et al. Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. Am J Cardiol. 2014;113:1532–1535.
   PubMed Web of Science ®Google Scholar
• Chahal NS, Drakopoulou M, Gonzalez-Gonzalez AM, et al. Resting aortic valve area at normal transaortic flow Rate reflects true valve area in suspected low-gradient severe aortic stenosis. JACC Cardiovasc Imaging. 2015;8:1133–1139.
   PubMed Web of Science ®Google Scholar
• Clavel MA, Dumesnil JG, Capoulade R, et al. Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1259–1267.
   PubMed Web of Science ®Google Scholar
• Kadem L, Dumesnil JG, Rieu R, et al. Impact of systemic hypertension on the assessment of aortic stenosis. Heart. 2005;91:354–361.
   PubMed Web of Science ®Google Scholar
• Côté N, Simard L, Zenses AS, et al. Impact of vascular hemodynamics on aortic stenosis evaluation: new insights into the pathophysiology of normal flow-small aortic valve area-low gradient pattern. J Am Heart Assoc. 2017;6(7):e006276.
   PubMed Web of Science ®Google Scholar
• Clavel MA, Messika-Zeitoun D, Pibarot P, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler-echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62:2329–2338.
   PubMed Web of Science ®Google Scholar
• Matthews CE, Pate RR, Jackson KL, et al. Exaggerated blood pressure response to dynamic exercise and risk of future hypertension. J Clin Epidemiol. 1998;51:29–35.
   PubMed Web of Science ®Google Scholar
• Jae SY, Franklin BA, Choo J, et al. Exaggerated exercise blood pressure response during treadmill testing as a predictor of future hypertension in men: A longitudinal study. Am J Hypertens. 2015;28:1362–1367.
   PubMed Web of Science ®Google Scholar
• Lauer MS, Pashkow FJ, Harvey SA, et al. Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease. J Am Coll Cardiol. 1995;26:1630–1636.
   PubMed Web of Science ®Google Scholar
• Saeed S, Mancia G, Rajani R, et al. The impact of exaggerated blood pressure response to treadmill exercise on outcome in patients with asymptomatic aortic stenosis. J Hypertens. 2018;36(e–Suppl 1):e297.
   Google Scholar
• Bratberg JA, Bulut E, Rieck AE, et al. Determinants of systolic blood pressure response during exercise in overweight subjects. Blood Press. 2014;23:200–205.
   PubMed Web of Science ®Google Scholar
• Monrad ES, Hess OM, Murakami T, et al. Abnormal exercise hemodynamics in patients with normal systolic function late after aortic valve replacement. Circulation. 1988;77:613–624.
   PubMed Web of Science ®Google Scholar
• Eleid MF, Nishimura RA, Sorajja P, et al. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013;128:1349–1353.
   PubMed Web of Science ®Google Scholar
• Lønnebakken MT, Rieck AE, Gerdts E. Contrast stress echocardiography in hypertensive heart disease. Cardiovasc Ultrasound. 2011 Nov 18;9: 33. .
   PubMed Web of Science ®Google Scholar
• Dahl JS, Christensen NL, Videbæk L, et al. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging. 2014;7:142–148.
   PubMed Web of Science ®Google Scholar
• Pibarot P. Aortic stenosis: flow matters. Heart. 2015;101:5–6.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Rossebø AB, Pedersen TR, et al. Relation of left ventricular mass to prognosis in initially asymptomatic mild to moderate aortic valve stenosis. Circ Cardiovasc Imaging. 2015;8(11):e003644.
   PubMed Web of Science ®Google Scholar
• Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46:291–298.
   PubMed Web of Science ®Google Scholar
• Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009;54:1003–1011.
   PubMed Web of Science ®Google Scholar
• Rieck AE, Gerdts E, Lønnebakken MT, et al. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). Cardiovasc Ultrasound. 2012;10:43.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Magne J. Valvuloarterial impedance in aortic stenosis: look at the load, but do not forget the flow. Eur J Echocardiogr. 2011;12:354–357.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Cioffi G, Rieck AE, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. JACC Cardiovasc Imaging. 2009;2:390–399.
   PubMed Web of Science ®Google Scholar
• Chockalingam A, Venkatesan S, Subramaniam T, et al. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J. 2004;147:E19.
   PubMed Web of Science ®Google Scholar
• Nielsen OW, Sajadieh A, Sabbah M, et al. Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS). Circulation. 2016;134:455–468.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Palmieri V, Sharpe N, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial. Circulation. 2001;104:1248–1254.
   PubMed Web of Science ®Google Scholar
• Ong KT, Delerme S, Pannier B, et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens. 2011;29:1034–1042.
   PubMed Web of Science ®Google Scholar
• Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18–33.
   PubMed Web of Science ®Google Scholar
• Cote N, Couture C, Pibarot P, et al. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves. Eur J Clin Invest. 2011;41:1172–1179.
   PubMed Web of Science ®Google Scholar
• Capoulade R, Clavel MA, Mathieu P, et al. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis. Eur J Clin Invest. 2013;43:1262–1272.
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291–1295.
   PubMed Web of Science ®Google Scholar
• O’Brien KD, Probstfield JL, Caulfield MT, et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med. 2005;165:858–862.
   PubMedGoogle Scholar
• Bang CN, Greve AM, Køber L, et al. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis. Int J Cardiol. 2014;175:492–498.
   PubMed Web of Science ®Google Scholar
• Chambers J. The left ventricle in aortic stenosis. Evidence for the use of angiotensin-converting enzyme inhibitors (Education in Heart). Heart. 2006;92:420–423.
   PubMed Web of Science ®Google Scholar
• Nadir MA, Wei L, Elder DH, et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol. 2011;58:570–576.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure (second of two parts). N Engl J Med. 1977;297:254–258.
   PubMed Web of Science ®Google Scholar
• Bang CN, Greve AM, Rossebø AB, et al. Antihypertensive treatment with β-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events. J Am Heart Assoc. 2017;27(12):e006709.
   Google Scholar
• Lund O, Kristensen LH, Baandrup U, et al. Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J. 1998;19:1099–1108.
   PubMed Web of Science ®Google Scholar
• Lund O, Emmertsen K, Dørup I, et al. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J. 2003;24:1437–1446.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92:1022–1029.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Gerdts E, Segadal L. Impact of hypertension on left ventricular hypertrophy regression and exercise capacity in patients operated for aortic valve stenosis. Scand Cardiovasc J. 2006;40:167–174.
   PubMed Web of Science ®Google Scholar
• Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956–966.
   PubMed Web of Science ®Google Scholar
• Imanaka K, Kohmoto O, Nishimura S, et al. Impact of postoperative blood pressure control on regression of left ventricular mass following valve replacement for aortic stenosis. Eur J Cardiothorac Surg. 2005;27:994–999.
   PubMed Web of Science ®Google Scholar
• Généreux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38:3351–3358.
   PubMed Web of Science ®Google Scholar
• Perlman GY, Loncar S, Pollak A, et al. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. JACC Cardiovasc Interv. 2013;6:472–478.
   PubMed Web of Science ®Google Scholar
• Yotti R, Bermejo J, Gutiérrez-Ibañes E, et al. Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement. J Am Coll Cardiol. 2015;65:423–433.
   PubMed Web of Science ®Google Scholar
• Coutinho T, Yam Y, Chow BJW, et al. Sex differences in associations of arterial compliance with coronary artery plaque and calcification burden. J Am Heart Assoc. 2017;6(8):e006079.
   PubMed Web of Science ®Google Scholar